These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 2500880)

  • 1. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation.
    Falk RH
    Ann Intern Med; 1989 Jul; 111(2):107-11. PubMed ID: 2500880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flecainide-Induced Atrial Flutter With 1:1 Conduction Complicated by Ventricular Fibrillation After Electrical Cardioversion.
    Colangelo T; Johnson D; Ho R
    Tex Heart Inst J; 2021 Jun; 48(2):. PubMed ID: 34086956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation.
    Berns E; Rinkenberger RL; Jeang MK; Dougherty AH; Jenkins M; Naccarelli GV
    Am J Cardiol; 1987 Jun; 59(15):1337-41. PubMed ID: 3109229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bundle branch reentry tachycardia: a possible mechanism of flecainide proarrhythmia effect].
    Saoudi N; Berland J; Cribier A; Letac B
    Arch Mal Coeur Vaiss; 1988 Apr; 81(4):537-41. PubMed ID: 3136716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder].
    Rienstra M; Wiesfeld AC; van Veldhuisen DJ; van Gelder IC
    Ned Tijdschr Geneeskd; 2006 May; 150(18):1027-31. PubMed ID: 16715868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of exercise-induced and spontaneous wide complex tachycardia during therapy with flecainide for complex ventricular arrhythmias: a probable proarrhythmic effect.
    Anastasiou-Nana MI; Anderson JL; Stewart JR; Crevey BJ; Yanowitz FG; Lutz JR; Johnson TA
    Am Heart J; 1987 May; 113(5):1071-7. PubMed ID: 3107362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tachycardia due to atrial flutter with rapid 1:1 conduction following treatment of atrial fibrillation with flecainide.
    Taylor R; Gandhi MM; Lloyd G
    BMJ; 2010 Mar; 340():b4684. PubMed ID: 20219811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias.
    Nathan AW; Camm AJ; Bexton RS; Hellestrand KJ
    Clin Cardiol; 1987 May; 10(5):317-22. PubMed ID: 3109795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
    Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac devices with class 1C antiarrhythmics: a potentially toxic combination.
    Apps A; Miller CP; Fellows S; Jones M
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26286909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise-induced ventricular tachycardia as a manifestation of flecainide toxicity.
    Hoffmann A; Wenk M; Follath F
    Int J Cardiol; 1986 Jun; 11(3):353-5. PubMed ID: 3721634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter.
    Van Gelder IC; Crijns HJ; Van Gilst WH; Van Wijk LM; Hamer HP; Lie KI
    Am J Cardiol; 1989 Dec; 64(19):1317-21. PubMed ID: 2511744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm.
    Botto GL; Bonini W; Broffoni T; Cappelletti G; Falcone C; Lombardi R; Paulesu A; Pedraglio E; Ferrari G
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2114-7. PubMed ID: 7845827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flecainide acetate in atrial flutter and fibrillation. The arrhythmogenic effects.
    Sihm I; Hansen FA; Rasmussen J; Pedersen AK; Thygesen K
    Eur Heart J; 1990 Feb; 11(2):145-8. PubMed ID: 2107078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inefficacy and proarrhythmic effects of flecainide and encainide for sustained ventricular tachycardia and ventricular fibrillation.
    Herre JM; Titus C; Oeff M; Eldar M; Franz MR; Griffin JC; Scheinman MM
    Ann Intern Med; 1990 Nov; 113(9):671-6. PubMed ID: 2121082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reduction of auricular fibrillation and tachycardia using intravenous flecainide].
    Cohen-Solal A; Juliard JM; Jaeger P; Farinotti P; Dahan M; Charlier P; Boujon B; Aumont MC
    Arch Mal Coeur Vaiss; 1987 Jul; 80(8):1290-6. PubMed ID: 3120666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of flecainide and mexiletine for the treatment of ventricular tachyarrhythmias.
    Jordaens LJ; Tavernier R; Vanmeerhaeghe X; Robbens E; Clement DL
    Pacing Clin Electrophysiol; 1990 Sep; 13(9):1127-35. PubMed ID: 1700388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flecainide therapy in patients treated for supraventricular tachycardia with near normal left ventricular function.
    Hughes MM; Trohman RG; Simmons TW; Castle LW; Wilkoff BL; Morant VA; Maloney JD
    Am Heart J; 1992 Feb; 123(2):408-12. PubMed ID: 1736577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events.
    Almroth H; Andersson T; Fengsrud E; Friberg L; Linde P; Rosenqvist M; Englund A
    J Intern Med; 2011 Sep; 270(3):281-90. PubMed ID: 21635583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.